This inventor holds 1 USPTO granted patent. Top assignee: Equispharm Co., Ltd. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: The Innovations of Cheol-Kyu Han
Introduction
Cheol-Kyu Han is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications in cancer treatment and inflammatory diseases.
Latest Patents
Cheol-Kyu Han holds a patent for "Fumagillol derivatives and preparing method thereof." This patent discloses a fumagillol compound that serves as an angiogenesis inhibiting agent. It demonstrates a superior angiogenesis inhibitory effect with reduced toxicity. Additionally, it functions as a cancer metastasis inhibitor and a therapeutic agent for various inflammatory diseases, including rheumatic disease, psoriasis, and diabetic retinopathy.
Career Highlights
Han is associated with Equispharm Co., Ltd., where he continues to innovate and develop new therapeutic solutions. His work has garnered attention for its potential impact on cancer treatment and other inflammatory conditions.
Collaborations
Some of his notable coworkers include Jeong-Hyeok Yoon and Seung-Moak Kim, who contribute to the collaborative efforts at Equispharm Co., Ltd.
Conclusion
Cheol-Kyu Han's work exemplifies the intersection of innovation and healthcare, showcasing the potential of his patented compounds in treating serious medical conditions. His contributions are paving the way for advancements in therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile